From pandemic preparedness and the rise of obesity drugs to personalised cancer care, infant health and loneliness as a global public health challenge, researchers at the University of Cambridge and beyond will take on some of the most urgent health questions facing the UK during the Cambridge Festival this March.
Running from 16 March to 2 April, the festival brings together world-leading scientists, clinicians, legal scholars and patient advocates to share new research, challenge assumptions and open debate on how health risks are changing, and how society, policy and medicine must respond.
Among the most prominent contributors are Professor Giles Yeo, one of the UK’s best-known voices on obesity and metabolism; Professors Charlotte Coles and Jean Abraham, whose research has helped transform breast cancer treatment worldwide; Dr Suzannah Rihn, Professor James Thaventhiran and Professor Ravi Gupta, leading figures in infectious disease and immunology; and researchers examining loneliness as a rising global health priority, following warnings from the World Health Organization and public health bodies internationally.
One of the Festival’s most high-profile health events takes place on 30 March, when Professor Giles Yeo tackles one of the most contested questions in modern medicine in In a post-Ozempic world, have we cured obesity?. Focusing on GLP-1 drugs such as Ozempic and Mounjaro, Yeo will explain how these treatments work, why they have transformed obesity care, and what remains unknown about their long-term safety and impact. A professor at the MRC Metabolic Diseases Unit and a familiar voice on BBC science programmes, Yeo is known for bringing rigorous research on appetite, weight and genetics into the public conversation.
The festival opens its health programme with Preparing for the next pandemic on 17 March, bringing together Dr Suzannah Rihn, Professor James Thaventhiran and Professor Ravi Gupta from the Cambridge Institute of Therapeutic Immunology and Infectious Disease. The session explores how pandemics begin, how viruses cross species barriers, how vaccines can be made more effective, and how factors such as obesity and ageing shape immune responses. It also addresses the challenge of virus variants, rapid diagnostics and the policy decisions needed to improve global readiness.
Cancer research and care feature strongly throughout the programme. The future of breast cancer care on 31 March brings together clinicians and patient advocates to explore how team science and lived experience are shaping research that matters to patients. Professor Charlotte Coles, Deputy Head of the Department of Oncology, will discuss clinical trials that have transformed breast radiotherapy, enabling more personalised treatment delivered in just one week, changing practice globally. She is joined by Professor Jean Abraham, Director of the Precision Breast Cancer Institute, whose work in whole-genome sequencing and the PARTNER trial is helping doctors identify smarter, kinder treatments while avoiding unnecessary side effects.
There will be a focus on equity, with a special screening and discussion, titled: Shades of Survival: Confronting global inequalities in breast cancer, on 31 March. The award-winning documentary examines disparities in breast cancer care for Black women across Africa, the UK and the US. Featuring contributions from Cambridge researchers alongside filmmakers and patients, the event highlights the global effort to close gaps in outcomes and access to care.
Battling brain cancer: Unspoken stories, on 25 March, brings together patients, carers, clinicians and researchers during Brain Cancer Awareness Month. Through first-hand accounts and discussion, the session shines a light on a disease that remains one of the most challenging to diagnose and treat, underscoring the importance of awareness, research and collaboration.
Public health is explored from multiple angles, including the environment. From dirty air to heatwaves: The environmental roots of long-term health conditions on 23 March examines how air pollution, rising temperatures and chemical exposure increase the risk of heart disease, diabetes and cancer, and what can be done to build healthier, more resilient communities in a changing climate.
Scientific innovation underpins many of the festival’s health events. AI and the future of public health on 25 March explores how artificial intelligence could be used responsibly to predict disease outbreaks, improve services and strengthen communities. The future of nanomedicine on 21 March sees Professor Ljiljana Fruk explain how nanotechnology may change how we diagnose, repair and restore the body, while The holistic immune system: Nerves, hormones and getting old on 27 March brings together Professors Menna Clatworthy, David Thomas and Eoin McKinney to uncover hidden regulators of immunity, from stress responses to metabolism and ageing.
The Cambridge Festival runs from 16 March to 2 April 2026. The full programme and tickets are available from 16 February here.
